The optimal timing to administer non-vitamin K oral anticoagulants (NOACs) in patients with acute ischemic stroke and atrial fibrillation is unclear. This prospective observational multicenter study evaluated the rates of early recurrence and major bleeding (within 90 days) and their timing in patients with acute ischemic stroke and atrial fibrillation who received NOACs for secondary prevention
OBJECTIVE: The optimal timing to start direct oral anticoagulants (DOACs) after an acute ischaemic s...
Introduction: There is uncertainty regarding the optimal timing for initiation of oral anticoagulati...
BACKGROUND: The safety of early initiation of anticoagulant therapy in patients with ischaemic strok...
Background: The optimal timing to administer non-vitamin K oral anticoagulants (NOACs) in patients w...
Background: The optimal timing to administer non–vitamin K oral anticoagulants (NOACs) in patients w...
Background-The optimal timing to administer non-vitamin K oral anticoagulants (NOACs) in patients wi...
Background and Purpose: The optimal timing for starting oral anticoagulant after an ischemic stroke ...
BACKGROUND AND PURPOSE: The best time for administering anticoagulation therapy in acute cardioembol...
Background and Purpose - The best time for administering anticoagulation therapy in acute cardioembo...
The optimal timing for starting oral anticoagulant after an ischemic stroke related to atrial fibril...
The balance between the risk of early stroke recurrence and haemorrhagiic transformation represents ...
Background and Purpose—The best time for administering anticoagulation therapy in acute cardioemboli...
Background: There are no evidence-based recommendations on the optimal time point to initiate non-vi...
Background: There are no evidence-based recommendations on the optimal time point to initiate non–vi...
OBJECTIVE: The optimal timing to start direct oral anticoagulants (DOACs) after an acute ischaemic s...
Introduction: There is uncertainty regarding the optimal timing for initiation of oral anticoagulati...
BACKGROUND: The safety of early initiation of anticoagulant therapy in patients with ischaemic strok...
Background: The optimal timing to administer non-vitamin K oral anticoagulants (NOACs) in patients w...
Background: The optimal timing to administer non–vitamin K oral anticoagulants (NOACs) in patients w...
Background-The optimal timing to administer non-vitamin K oral anticoagulants (NOACs) in patients wi...
Background and Purpose: The optimal timing for starting oral anticoagulant after an ischemic stroke ...
BACKGROUND AND PURPOSE: The best time for administering anticoagulation therapy in acute cardioembol...
Background and Purpose - The best time for administering anticoagulation therapy in acute cardioembo...
The optimal timing for starting oral anticoagulant after an ischemic stroke related to atrial fibril...
The balance between the risk of early stroke recurrence and haemorrhagiic transformation represents ...
Background and Purpose—The best time for administering anticoagulation therapy in acute cardioemboli...
Background: There are no evidence-based recommendations on the optimal time point to initiate non-vi...
Background: There are no evidence-based recommendations on the optimal time point to initiate non–vi...
OBJECTIVE: The optimal timing to start direct oral anticoagulants (DOACs) after an acute ischaemic s...
Introduction: There is uncertainty regarding the optimal timing for initiation of oral anticoagulati...
BACKGROUND: The safety of early initiation of anticoagulant therapy in patients with ischaemic strok...